Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma

Journal of Molecular Medicine

Volumn 90, Issue 4, 2012, Pages 427-434

  Lee, Yu Hsiang ^a,b   Kim, Jae Hoon ^b,d   Zhou, Hui ^b   Kim, Bo Wook ^e   Wong, David T ^b,c  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d Yonsei University College of Medicine   (South Korea)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ovarian cancer; RNA; Saliva; Salivary diagnostics

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; TRANSCRIPTOME;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA MICROARRAY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; OVARY CANCER; REAL TIME POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SEROUS PAPILLARY ADENOCARCINOMA; TRANSCRIPTOMICS;

ADENOCARCINOMA, PAPILLARY; ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; RNA, MESSENGER; SALIVA; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84862544448     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0829-0     Document Type: Article

References (35)

1. Kandalaft LE, Motz GT, Duraiswamy J, Coukos G (2011) Tumor immune surveillance and ovarian cancer: Lessons on immune mediated tumor rejection or tolerance. Cancer Metastasis Rev 30:141-151
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA Cancer J Clin 59:225-249
3. Verheijen RHM, Von Mensdorff-Pouilly S, Van Kamp GJ, Kenemans P (1999) CA125: Fundamental and clinical aspects. Cancer Biol 9:117-124
4. van Haaften-Day C, Shen Y, Xu F, Yu Y, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Bast RC Jr, Hacker NF (2001) OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: A critical appraisal. Cancer 92:2837-2844 (Pubitemid 33091920)
5. Donach M, Yu Y, Artioli G, Banna G, Feng W, Bast RC Jr, Zhang Z, Nicoletto MO, Donach M, Yu Y et al (2010) Combined use of biomarkers for detection of ovarian cancer in high-risk women. Tumour Biol 31:209-215
6. Fleischer A (eds) (1997) Ovarian cancer. In: Fleischer AC, Javitt MC, Jeffrey RB, Jones HW Clinical Gynecologic Imaging. Lippincott Williams & Wilkins, Philadelphia, pp 107
7. Bast RC Jr (2004) Early detection of ovarian cancer: New technologies in pursuit of a disease that is neither common nor rare. Trans Am Clin Climatol Assoc 115:233-248
8. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC et al (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572-577 (Pubitemid 34178440)
9. Tchagang AB, Tewfik AH, DeRycke MS, Skubitz KM, Skubitz AP (2008) Early detection of ovarian cancer using group biomarkers. Mol Cancer Ther 7:27-37
10. Wei SH, Balch C, Paik HH, Kim YS, Baldwin RL, Liyanarachchi S, Li L, Wang Z, Wan JC, Davuluri RV (2006) Prognostic DNA methylation biomarkers in ovarian cancer. Clin Cancer Res 12:2788-2794
11. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, Zhou H, Henry S, Vissink A, Pijpe J et al (2007) Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 56:3588-3600 (Pubitemid 350100692)
12. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH et al (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10:8442-8450 (Pubitemid 40053408)
13. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, Wong DT (2009) Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15:5473-5477
14. Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, Roberts CT, Nagalla SR (2009) Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 8:239-245
15. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT (2010) Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 138:949-957
16. Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B et al (2010) Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 5:e15573
17. Chen DX, Schwartz PE, Li FQ (1990) Saliva and serum CA 125 assays for detecting malignant ovarian tumors. Obstet Gynecol 75:701-704 (Pubitemid 20110195)
18. Boucaud M, Pinguet F, Poujol S, Romieu G, Cupissol D, Astre C, Culine S, Bressolle F (2001) Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer. Eur J Cancer 37:2357-2364 (Pubitemid 33097471)
19. Ballantyne J (2007) Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res 13:1350-1351
20. Li Y, Zhou X, St John MA, Wong DT (2004) RNA profiling of cell-free saliva using microarray technology. J Dent Res 83:199-203 (Pubitemid 41715238)
21. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL et al (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622
22. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577 (Pubitemid 23118304)
23. Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI, Andersen JS, Schumacher V, Royer-Pokora B, Mann M et al (2004) BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol 24:537-549 (Pubitemid 38057907)
24. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, Wong DT (2006) Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24:1754-1760 (Pubitemid 46622147)
25. Arlt A, Schäfer H (2011) Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis. Eur J Cell Biol 90:545-552
26. Li XJ, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A, Peng LX, Lu WH, Zhang Z, Petillo D et al (2011) Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res 71:3162-3172
27. Hernádi Z, Molnár V, Juhász B, Pólka R, Margitai B (1992) Predictive value of the tumor marker combination CA-125 and beta-2-microglobulin in ovarian cancer. Zentralbl Gynakol 114:6-9
28. Yang HS, Li Y, Deng HX, Peng F (2009) Identification of beta2- microglobulin as a potential target for ovarian cancer. Cancer Biol Ther 8:2323-2328
29. Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, Thompson PJ, Wilkens LR, Tung KH, Ness RB, Goodman MT (2004) Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 95:672-679 (Pubitemid 39592536)
30. Cheng L, Lu W, Kulkarni B, Pejovic T, Yan X, Chiang JH, Hood L, Odunsi K, Lin B (2010) Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies. Gynecol Oncol 117:159-169
31. Landman AD, Sanford LM, Howland BE, Dawes C, Pritchard ET (1976) Testosterone in human saliva. Experientia 32:940-941
32. Hammond GL, Langley MS (1986) Identification and measurement of sex hormone binding globulin (SHBG) and corticosteroid binding globulin (CBG) in human saliva. Acta Endocrinol (Copenh) 112:603-608 (Pubitemid 16040651)
33. Kubagawa H, Bertoli LF, Barton JC, Koopman WJ, Mestecky J, Cooper MD (1987) Analysis of paraprotein transport into saliva by using anti-idiotype antibodies. J Immunol 138:435-439 (Pubitemid 17002201)
34. Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, Wolinsky LE, Farrell J, Eibl G, Wong DT (2009) Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS One 4:e5875
35. Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD (2008) Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: Standards for study design. J Natl Cancer Inst 100:1432-1438